Thomas Borén
Corporate Officer/Principal presso Umea Universitet
Profilo
Thomas Borén was the founder of Helicure AB, which he founded in 2005 and served as Chief Scientific Officer until 2011.
Currently, he holds the title of Professor at Umea Universitet.
Posizioni attive di Thomas Borén
| Società | Posizione | Inizio |
|---|---|---|
| Umea Universitet | Corporate Officer/Principal | - |
Precedenti posizioni note di Thomas Borén
| Società | Posizione | Fine |
|---|---|---|
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Thomas Borén
